CN101564476B - Chinese medicament for treating coronary heart disease - Google Patents
Chinese medicament for treating coronary heart disease Download PDFInfo
- Publication number
- CN101564476B CN101564476B CN2008101047809A CN200810104780A CN101564476B CN 101564476 B CN101564476 B CN 101564476B CN 2008101047809 A CN2008101047809 A CN 2008101047809A CN 200810104780 A CN200810104780 A CN 200810104780A CN 101564476 B CN101564476 B CN 101564476B
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- heart disease
- coronary heart
- chinese
- radix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention belongs to the field of Chinese medicaments for treating heart diseases, provides a Chinese medicament for treating the coronary heart disease aiming at good effect and quick response. The Chinese medicament is prepared from radix salviae miltiorrhizae, panax pseudoginseng, calamus, glossy ganoderma, angelica, garden balsam seed and other Chinese medicaments, has the functions of supporting body resistance and consolidating constitution, invigorating vital energy and nourishing blood, promoting blood circulation by removing blood stasis, nourishing the heart and relieving pains, and has the advantages of significant effect and quick response.
Description
Technical field
The invention belongs to the cardiopathic field of Chinese medicines of treatment.
Background technology
Be intended to treat the field of Chinese medicines of coronary heart disease at present, exist the deficiency of several aspects: the one, effect is obvious inadequately; The 2nd, it is slower to take effect.Many patients with coronary heart disease can not get effective control at feeling of oppression and pain in the chest, and outbreak has influenced quality of life and life span repeatedly, and patient and family members thereof are satisfied inadequately to this.
At problem set forth above, the invention provides a kind of Chinese medicine for the treatment of coronary heart disease, it can solve, and this type of Chinese medicine effect was obvious inadequately in the past, the slower problem that takes effect, effective, instant effect, it is remarkable to have effect, the advantage of quick result.
Summary of the invention
The present invention is achieved through the following technical solutions:
1, a kind of Chinese medicine for the treatment of coronary heart disease is taked the raw material of Chinese medicine preparation, and filling a prescription is (by weight):
Radix Salviae Miltiorrhizae 2---15 parts of 15 portions of Radix Notoginseng 2---15 portions of Rhizoma Acori Gramineis 2---
Ganoderma 1.5---15 parts of 10 parts of Radix Angelicae Sinensis 3---22 parts of Semen Impatientis 2---
The Chinese medicine of this treatment coronary heart disease is made by following method:
(1) by above-mentioned weight ratio, Radix Salviae Miltiorrhizae, Rhizoma Acori Graminei, Radix Angelicae Sinensis, Semen Impatientis are extracted through conventional water extraction process, make the extractum fine powder;
(2) by above-mentioned weight ratio, Radix Notoginseng, Ganoderma are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder; As required, can be made into Chinese medicine electuary, granule, powder, capsule, watered pill, tablets and other formulations.
The present invention is according to the folk tradition prescription, and the theory according to traditional Chinese medical science the body resistance strengthening and constitution consolidating, blood circulation promoting and blood stasis dispelling develops meticulously.According to theory of Chinese medical science, coronary heart disease is venation numbness resistance, and the QI and blood loss due to the hypofunction of YANG QI in chest, poor blood circulation, is controlled when benefiting QI and nourishing blood, blood circulation promoting and blood stasis dispelling.Ganoderma QI invigorating in the side, the body resistance strengthening and constitution consolidating, big tonifying five ZANG-organs; Chinese Angelica blood replonishing is invigorated blood circulation; We's compatibility Radix Salviae Miltiorrhizae, Radix Notoginseng, Semen Impatientis three diminishing-stagnant of blood Chinese medicines; The Radix Salviae Miltiorrhizae blood-enriching and blood-promoting circulation nourishes heart, the analgesic therapy of Radix Notoginseng dissipating blood stasis heart tonifying, Semen Impatientis the invigorate blood circulation stasis of blood, removing blood stasis removing food stagnancy clearly; Assistant is with Rhizoma Acori Graminei inducing resuscitation and resolving phlegm, the calmness of calming the nerves.All medicine compatibilities bring out the best in each other, and play the body resistance strengthening and constitution consolidating altogether, benefiting QI and nourishing blood, and blood circulation promoting and blood stasis dispelling, the merit of the analgesia of nourishing heart, effective, instant effect, it is remarkable to have effect, the advantage of quick result.
The specific embodiment
By following embodiment the present invention is done and to specify:
1, get following prescription (weight is unit by gram):
Radix Salviae Miltiorrhizae 50 gram Radix Notoginseng 50 gram Rhizoma Acori Gramineis 35 grams
Ganoderma 25 gram Radix Angelicae Sinensis 35 gram Semen Impatientis 36 grams
Weight in accordance with regulations, with conventional water extraction process Radix Salviae Miltiorrhizae, Rhizoma Acori Graminei, Radix Angelicae Sinensis, Semen Impatientis are extracted, make extractum fine powder 61.6 grams, Radix Notoginseng, Ganoderma are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder, make fine particle, the capsule of packing into No. 0 is made 487 of Chinese medicinal capsules, and every capsules includes Chinese medicine fine powder and extract 0.28 gram.
2, get following prescription (weight is unit by gram):
Radix Salviae Miltiorrhizae 140 gram Radix Notoginseng 110 gram Rhizoma Acori Gramineis 90 grams
Ganoderma 60 gram Radix Angelicae Sinensis 120 gram Semen Impatientis 90 grams
By above-mentioned same method, make 1394 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
3, get following prescription (weight is unit by gram):
Radix Salviae Miltiorrhizae 220 gram Radix Notoginseng 220 gram Rhizoma Acori Gramineis 180 grams
Ganoderma 100 gram Radix Angelicae Sinensis 230 gram Semen Impatientis 170 grams
By above-mentioned same method, make 2142 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
4, get following prescription (by weight):
0.3 part of 0.6 portion of Rhizoma Acori Graminei of 0.5 portion of Radix Notoginseng of Radix Salviae Miltiorrhizae
0.4 part of 0.8 part of Semen Impatientis of 0.3 part of Radix Angelicae Sinensis of Ganoderma
By above-mentioned same method, make Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
5, get following prescription (by weight):
18 parts of 16 portions of Rhizoma Acori Gramineis of 20 portions of Radix Notoginseng of Radix Salviae Miltiorrhizae
15 parts of 22 parts of Semen Impatientis of 9 parts of Radix Angelicae Sinensis of Ganoderma
By above-mentioned same method, make Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
Clinical data:
The present invention is an example with traditional Chinese medical science coronary heart disease, through 23 routine clinical observations.Selecting tcm diagnosis coronary heart disease is standard: limb is soft unable, chest distress and palpitation symptoms, and precordialgia, arrhythmia, the visible T ripple of electrocardiogram is unusual during outbreak.As above symptom can be made a definite diagnosis.In making a definite diagnosis the object of observation, male's 14 examples, women's 9 examples do not have other serious disease, and the age is 32 years old-73 years old, 55.4 years old mean age.
Efficacy determination:
1, produce effects: body constitution strengthens, and on one's body energetically, uncomfortable in chest, cardiopalmus, precordialgia is obviously alleviated or disappear, and heart district is comfortable, and electrocardiogram is normal.
2, effective: symptoms such as uncomfortable in chest, cardiopalmus, chest pain are alleviated to some extent.
3, invalid: the disease no change.
During clinical experiment, withdraw other medicines and health nutrient.Taking Chinese medicinal capsule of the present invention, observed 3 months, is a course of treatment.Instructions of taking: every day 3 times, each 3 capsules, every capsules include Chinese medicine fine powder and extract 0.28 gram, warm water delivery service after meal, symptom promptly has alleviation after 1 month, take 3 months after, symptom has clear improvement.23 philtrums of clinical experiment, produce effects 9 people, effective 11 people, invalid 3 people, total effective rate 86.9%.
Claims (1)
1. Chinese medicine for the treatment of coronary heart disease, it is characterized in that: it is to make with the raw material of Chinese medicine of following weight ratio, its Chinese medicine proportioning raw materials is:
Radix Salviae Miltiorrhizae 2---15 parts of 15 portions of Radix Notoginseng 2---15 portions of Rhizoma Acori Gramineis 2---
Ganoderma 1.5---15 parts of 10 parts of Radix Angelicae Sinensis 3---22 parts of Semen Impatientis 2---
The Chinese medicine of this treatment coronary heart disease is made by following method:
(1) by above-mentioned weight ratio, Radix Salviae Miltiorrhizae, Rhizoma Acori Graminei, Radix Angelicae Sinensis, Semen Impatientis are extracted through conventional water extraction process, make the extractum fine powder;
(2) by above-mentioned weight ratio, Radix Notoginseng, Ganoderma are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder; Make Chinese medicine granules, powder, capsule, watered pill, Tabules.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2008101047809A CN101564476B (en) | 2008-04-23 | 2008-04-23 | Chinese medicament for treating coronary heart disease |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2008101047809A CN101564476B (en) | 2008-04-23 | 2008-04-23 | Chinese medicament for treating coronary heart disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101564476A CN101564476A (en) | 2009-10-28 |
| CN101564476B true CN101564476B (en) | 2011-04-20 |
Family
ID=41280952
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2008101047809A Expired - Fee Related CN101564476B (en) | 2008-04-23 | 2008-04-23 | Chinese medicament for treating coronary heart disease |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101564476B (en) |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1895478A (en) * | 2006-06-20 | 2007-01-17 | 蒋介勇 | Chinese medicine for heart disease |
-
2008
- 2008-04-23 CN CN2008101047809A patent/CN101564476B/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1895478A (en) * | 2006-06-20 | 2007-01-17 | 蒋介勇 | Chinese medicine for heart disease |
Non-Patent Citations (2)
| Title |
|---|
| 刘德泉.冠心病的中药运用规律探讨.《光明中医》.1994,第14卷(第83期),第14－16页. * |
| 韩学杰.冠心病从痰论治心得.《吉林省中医药学会心病专业委员会成立暨第一次学术研讨会论文集》.2007,第21-26页. * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101564476A (en) | 2009-10-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101564505B (en) | Chinese medicament for treating pulmonary heart disease | |
| CN101843829B (en) | Chinese medicament for treating pulmonary heart diseases | |
| CN101843660B (en) | Chinese medicament for treating tachycardia | |
| CN101850055B (en) | Chinese medicament for treating coronary heart diseases | |
| CN101564476B (en) | Chinese medicament for treating coronary heart disease | |
| CN101843717B (en) | Chinese medicament for treating coronary disease | |
| CN101843679B (en) | Chinese medicament for treating cervical spondylosis | |
| CN101850017B (en) | Chinese medicament for treating asthma | |
| CN101537068B (en) | Chinese medicine for treating angina | |
| CN101843753B (en) | Chinese medicament for treating angina | |
| CN101843644B (en) | Chinese medicament for treating tachycardia | |
| CN101843755A (en) | Chinese medicament for treating diabetic cardiopathy | |
| CN101843758B (en) | Chinese medicament for treating coronary disease | |
| CN101843844B (en) | Chinese medicament for treating pulmonary heart diseases | |
| CN101879259B (en) | Traditional Chinese medicine for treating pulmonary heart diseases | |
| CN101843832B (en) | Chinese medicament for treating coronary disease | |
| CN101849985B (en) | Chinese medicament for treating tachycardia | |
| CN101850079B (en) | Chinese medicament for treating asthma | |
| CN101843830B (en) | Chinese medicament for treating pulmonary heart diseases | |
| CN101843835B (en) | Chinese medicament for treating coronary diseases | |
| CN101850014B (en) | Chinese medicament for treating asthma | |
| CN101843793B (en) | Chinese medicament for treating tachycardia | |
| CN101850034B (en) | Chinese medicament for treating angina | |
| CN101843797A (en) | Chinese medicament for treating pulmonary heart diseases | |
| CN101843700A (en) | Chinese medicament for treating coronary disease |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: RUGAO RICH STEEL MACHINERY PARTS CO., LTD. Free format text: FORMER OWNER: BEIJING LVYUANQIUZHENG TECHNOLOGY DEVELOPMENT CO., LTD. Effective date: 20130710 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 100040 SHIJINGSHAN, BEIJING TO: 226500 NANTONG, JIANGSU PROVINCE |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20130710 Address after: 226500, Jiangsu, Rugao moved by the town, moved through the village of twenty-four groups Patentee after: Rugao Fu Steel Machinery Fittings Co., Ltd. Address before: 100040 Beijing city Shijingshan District street Babaoshan Lugu Village District No. 7 Building 10 room 602 Patentee before: Beijing Lvyuanqiuzheng Technology Development Co., Ltd. |
|
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20110420 Termination date: 20170423 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |